[ref] How does a GLP-1 agonist work for weight loss By binding to the GLP-1 receptor, GLP-1 RAs mimic the effects of having eaten and released GLP-1
Exenatide extended-release (Bydureon BCise): 2 mg once weekly for type 2 diabetes
Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are both FDA-approved specifically for weight management in adults with obesity or overweight with a weight-related condition regardless of whether diabetes is present
Maik Wiedenbach is a Hall of Fame swimmer turned bodybuilding champion and fitness model featured in Muscle & Fitness and Mens Journal
Advertisement Supported by Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits
New evidence shows that GLP-1based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic potential beyond metabolism